KINIKSA PHARMACEUTICALS LTD

CUSIP: G5269C101 Class: Foreign Stock

Swiss National Bank's Holding History (CIK: 0001582202)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 55,600 Value ($000) $1,097 Avg Close — Range —
Q4 2023
Shares 55,600 Value ($000) $975 Avg Close — Range —
Q3 2023
Shares 60,700 Value ($000) $1,054 Avg Close — Range —
Q2 2023
Shares 60,700 Value ($000) $855 Avg Close — Range —
Q1 2023
Shares 67,100 Value ($000) $722 Avg Close — Range —
Q4 2022
Shares 74,900 Value ($000) $1,122 Avg Close — Range —
Q3 2022
Shares 72,300 Value ($000) $928 Avg Close — Range —
Q2 2022
Shares 72,300 Value ($000) $701 Avg Close — Range —
Q1 2022
Shares 60,100 Value ($000) $597 Avg Close — Range —
Q4 2021
Shares 52,800 Value ($000) $621 Avg Close — Range —
Q3 2021
Shares 52,800 Value ($000) $601 Avg Close — Range —
Q2 2021
Shares 52,800 Value ($000) $736 Avg Close — Range —
Q1 2021
Shares 54,200 Value ($000) $1,003 Avg Close — Range —
Q4 2020
Shares 52,500 Value ($000) $928 Avg Close — Range —
Q3 2020
Shares 52,500 Value ($000) $804 Avg Close — Range —
Q2 2020
Shares 38,600 Value ($000) $984 Avg Close — Range —
Q3 2019
Shares 19,500 Value ($000) $166 Avg Close — Range —
Q2 2019
Shares 19,500 Value ($000) $264 Avg Close — Range —